Skip to content

Personalis

US · PSNL #2890 by market cap Listed 2019
14.27 -0.45 -3.06%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 8 in the most recent period (2026/Q3).
  • Total institutional ownership fell 7.7 percentage points.

Ownership vs. money flow

Diverging

Institutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
73.73% -7.72pp
Institutions
197 +8
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund39.56%
Public Company15.36%
VC/PE Fund11.67%
Hedge Fund4.04%
Private Company1.66%
Individual/Insider1.21%
Government Pension Fund0.70%
Insurance Company0.69%
Other25.06%

Top holders as of 2026-07-19

Tempus AI, Inc. 12.03% · 13.04M sh
ARK Investment Management LLC 6.57% · 7.12M sh
BlackRock 6.40% · 6.93M sh
Lightspeed Management Company, LLC 5.63% · 6.10M sh
Columbia Management Investment Advisers, LLC 5.61% · 6.09M sh
Deep Track Capital, LP 3.69% · 4.00M sh
abrdn plc 3.21% · 3.48M sh
Vanguard Capital Management, LLC 3.02% · 3.27M sh
Casdin Capital, LLC 2.35% · 2.55M sh
Kennedy Capital Management LLC 2.18% · 2.36M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 29 buys · 21 sells

NameRoleStake
Tempus AI, Inc. -- 12.03%
Aaron Tachibana Chief Financial Officer 0.18%
Richard Chen President & Chief Medical Officer 0.12%
Christopher Hall Chief Executive Officer 0.12%
Stephen Moore Chief Legal Officer 0.08%
Lonnie Shoff Independent Director 0.03%
Woodrow Myers Independent Director 0.02%
Olivia Bloom Independent Director 0.02%
Karin Eastham Independent Chairperson 0.01%
Arthur Bowman Independent Director 0.01%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-02 Christopher Hall Chief Executive Officer Open Market Disposition -29,112 $15.87
2026-09-17 Richard Chen President & Chief Medical Officer Open Market Disposition -3,998 $16.22
2026-09-17 Aaron Tachibana Chief Financial Officer Open Market Disposition -2,931 $16.22
2026-09-17 Stephen Moore Chief Legal Officer Open Market Disposition -2,068 $16.22
2026-09-17 Christopher Hall Chief Executive Officer Open Market Disposition -7,459 $16.22
2026-07-14 Richard Chen President & Chief Medical Officer Derivative Exercise and Sale -100,000 $2.44–15.15
2026-07-08 Christopher Hall Chief Executive Officer Derivative Exercise and Sale -100,000 $1.61–15.08
2026-06-28 Aaron Tachibana Chief Financial Officer Derivative Exercise and Sale -4,982 $5.32–14.00
2026-06-25 Aaron Tachibana Chief Financial Officer Derivative Exercise and Sale -51,251 $5.32–13.18
2026-06-25 Christopher Hall Chief Executive Officer Derivative Exercise and Sale -100,000 $1.61–13.15
2026-06-03 Aaron Tachibana Chief Financial Officer Derivative Exercise and Sale -40,000 $9.16–12.01
2026-05-28 Aaron Tachibana Chief Financial Officer Derivative Exercise and Sale -38,799 $9.16–11.58
2026-05-28 Christopher Hall Chief Executive Officer Derivative Exercise and Sale -100,000 $1.61–11.02
2026-05-27 Christopher Hall Chief Executive Officer Intent to Sell (Form 144) -100,000 $9.49
2026-05-11 Kenneth Widder Independent Director Other Acquisition +6,250 --
2026-05-11 Kenneth Widder Independent Director Other Derivative Acquisition +37,500 $6.04
2026-05-11 Karin Eastham Independent Chairperson Other Acquisition +6,250 --
2026-05-11 Karin Eastham Independent Chairperson Other Derivative Acquisition +37,500 $6.04
2026-05-11 Arthur Bowman Independent Director Other Acquisition +6,250 --
2026-05-11 Arthur Bowman Independent Director Other Derivative Acquisition +37,500 $6.04

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Personalis discussion 0 comments

Add a comment